NATERA 20-043-NCP "BESPOKE IO"

Colon, Lung - Non Small Cell Lung Cancer, Melanoma - BESPOKE IO

NATERA 20-043-NCP "BESPOKE IO"

Objective

BESPOKE Study of ctDNA Guided Immunotherapy (BESPOKE IO)

Principal Investigator(s)
Syed Jilani, MD

Clinical Trial Categories

  • Hunt Cancer Institute Active Clinical Trials